VALERIY SABODASH
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology SARASOTA, FL NPI 1003008533
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology FL EISAI INC. All categories
General Payments — all program years on this page
$31,624.93
- Category: General Payments
- Program years: PY2018–2024
- Record count: 531
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $9,244.98 across 69 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for serving as faculty or as a speaker for a medical education program | $6,205.00 | 10 |
| Food and Beverage | $1,874.68 | 55 |
| Consulting Fee | $1,095.00 | 1 |
| Travel and Lodging | $70.30 | 3 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| EISAI INC. | $7,970.35 | 28 |
| Alexion Pharmaceuticals, Inc. | $261.14 | 8 |
| SK Life Science, Inc. | $229.49 | 4 |
| ABBVIE INC. | $184.23 | 9 |
| Alnylam Pharmaceuticals Inc. | $116.56 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $83.99 | 3 |
| Lilly USA, LLC | $83.91 | 3 |
| UCB, Inc. | $64.14 | 3 |
| ARGENX US, INC. | $56.10 | 2 |
| Genentech USA, Inc. | $51.37 | 2 |
| Vanda Pharmaceuticals Inc. | $49.66 | 2 |
| Amneal Pharmaceuticals LLC | $27.94 | 1 |
| Biogen, Inc. | $27.22 | 1 |
| Otsuka America Pharmaceutical, Inc. | $22.54 | 1 |
| EMD Serono, Inc. | $16.34 | 1 |
By program year
Records — PY2024 (69)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.